Fear of Progression in Multiple Sclerosis: Evaluation of Existing Patient-Reported Outcomes (PRO) Instruments

Author(s)

Suminski N
Parexel, Lafayette, CA, USA

OBJECTIVES: Multiple sclerosis (MS) is a chronic, progressive disease characterized by debilitating symptoms and causes great psychological and emotional distress. While fear of disease progression (FoP) has been widely assessed in oncology and other chronic conditions, FoP has been less studied in MS and prevalence of suitable patient reported outcomes (PRO) is unclear. This study aimed to identify existing instruments that have been used to measure FoP, and related concepts, in people with MS (PwMS).

METHODS: A literature review was conducted in Embase and Medline (December 2022). Search criteria were developed to identify MS studies utilizing PROs measuring FoP, worry, and health anxiety, among other terms. A supplementary search (Google Scholar) identified additional records not captured in the primary review.

RESULTS: 212 records were identified in the primary search and six records from the supplementary search. Following screening, sixty records were reviewed in full, from which thirty-nine PRO instruments were identified. The Hospital Anxiety and Depression Scale (HADS), a generic instrument, was the most prevalent questionnaire, followed by two MS PROs (MS Impact Scale [MSIS-29] and MS Quality of Life [MSQoL-54]). The Fear of Relapse Scale (FoR) and Functional Assessment of MS (FAMs) were the most relevant disease-specific measures as they contained FoP and health anxiety related items. The Fear of Progression Questionnaire (FOP-Q) was the most relevant generic measure, though utilized less frequently.

CONCLUSIONS: Many PRO instruments (e.g., HADS) have been used to measure emotional wellbeing in MS yet may not specifically assess the worry or fear of disease progression. PROs which focus on these concepts (e.g., FoP-Q) have been utilized, but lack MS-specific items. Recently, new PROs have been developed (e.g., FoR) in MS but are not widely implemented. As such, the development and implementation of MS-specific instruments, which evaluate the nuanced emotional and psychological experiences of PwMS, is supported.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)

Code

PCR213

Topic

Clinical Outcomes, Patient-Centered Research, Study Approaches

Topic Subcategory

Clinical Outcomes Assessment, Literature Review & Synthesis, Patient-reported Outcomes & Quality of Life Outcomes

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×